Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gibson

Showing results (681-690 of 737) with videos related to

Pageof 74
Sort By:
BMC Cardiovascular Disorders|August 8, 2023
Post-COVID-19 illness and associations with sex and genderKenneth Mangion, Andrew J Morrow, Robert Sykes, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a DecadeJiayu Yang, Lin Yang, Bryan Tordon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2019
Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe diseasePriya S Kishnani, James B Gibson, Michael J Gambello, et al.
Drug and Alcohol Dependence|November 11, 2022
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort studyNicholas A Livingston, Michael Davenport, Michael Head, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective studySi Houn Hahn, David Kronn, Nancy D Leslie, et al.
Leukemia & Lymphoma|October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials GroupMatthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
Human Mutation|May 28, 2010
Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological?Przemyslaw Szafranski, Christian P Schaaf, Richard E Person, et al.
Bone Marrow Transplantation|June 9, 2015
Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromesR Peffault de Latour, C Peters, B Gibson, et al.
Cardiology in the Young|August 23, 2021
Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohortBarry J Byrne, Steven D Colan, Priya S Kishnani, et al.
Human Mutation|August 13, 2015
Expanding the Molecular and Clinical Phenotype of SSR4-CDGBobby G Ng, Kimiyo Raymond, Martin Kircher, et al.
Pageof 74

Showing results (681-690 of 737) with videos related to

Sort By:
Pageof 74
BMC Cardiovascular Disorders|August 8, 2023
Post-COVID-19 illness and associations with sex and genderKenneth Mangion, Andrew J Morrow, Robert Sykes, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a DecadeJiayu Yang, Lin Yang, Bryan Tordon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 16, 2019
Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe diseasePriya S Kishnani, James B Gibson, Michael J Gambello, et al.
Drug and Alcohol Dependence|November 11, 2022
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort studyNicholas A Livingston, Michael Davenport, Michael Head, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective studySi Houn Hahn, David Kronn, Nancy D Leslie, et al.
Leukemia & Lymphoma|October 19, 2016
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials GroupMatthew D Seftel, John Kuruvilla, Tom Kouroukis, et al.
Human Mutation|May 28, 2010
Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological?Przemyslaw Szafranski, Christian P Schaaf, Richard E Person, et al.
Bone Marrow Transplantation|June 9, 2015
Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromesR Peffault de Latour, C Peters, B Gibson, et al.
Cardiology in the Young|August 23, 2021
Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohortBarry J Byrne, Steven D Colan, Priya S Kishnani, et al.
Human Mutation|August 13, 2015
Expanding the Molecular and Clinical Phenotype of SSR4-CDGBobby G Ng, Kimiyo Raymond, Martin Kircher, et al.
Pageof 74